Global impacts of COVID‐19 pandemic on sexual and reproductive health services: An international comparative study on primary care from the INTRePID Consortium
AbstractObjectiveTo understand how the COVID‐19 pandemic has impacted sexual and reproductive health (SRH) visits.DesignAn ecological study comparing SRH services volume in different countries before and after the onset of the COVID‐19 pandemic.SettingSeven countries from theINTernational ConsoRtium ofPrimary Care BIgData Researchers (INTRePID) across four continents.PopulationOver 3.8 million SRH visits to primary care physicians in Australia, China, Canada, Norway, Singapore, Sweden and the USA.MethodsDifference in average SRH monthly visits before and during the pandemic, with negative binomial regression modelling to compare predicted and observed number of visits during the pandemic for SRH visits.Main outcome measuresMonthly number of visits to primary care physicians from 2018 to 2021.ResultsDuring the pandemic, the average volume of monthly SRH visits increased in Canada (15.6%, 99% CI 8.1–23.0%) where virtual care was pronounced. China, Singapore, Sweden and the USA experienced a decline (−56.5%, 99% CI −74.5 to −38.5%; −22.7%, 99% CI −38.8 to −6.5%; −19.4%, 99% CI −28.3 to −10.6%; and −22.7%, 99% CI −38.8 to −6.5%, respectively); while Australia and Norway showed insignificant changes (6.5%, 99% CI −0.7 to –13.8% and 1.7%, 99% CI −6.4 to –9.8%). The countries that maintained (Australia, Norway) or surpassed (Canada) pre‐pandemic visit rates had the greatest use of virtual care.ConclusionsIn‐person SRH visits to primary care decreased during the pandemic. Virtual care seemed to counterbalance that decline. Although cervical cancer screening appeared insensitive to virtual care, strategies such as incorporating self‐collected samples for HPV testing may provide a solution in a future pandemic.
